Patents by Inventor Said Mohamed Anwar Elgendy

Said Mohamed Anwar Elgendy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6387881
    Abstract: Peptides which act as inhibitors or substrates of thrombin are provided.
    Type: Grant
    Filed: December 3, 1998
    Date of Patent: May 14, 2002
    Assignee: Trigen LTD
    Inventors: Vijay Vir Kakkar, John Joseph Deadman, Goran Karl Claeson, Leifeng Cheng, Naoyashi Chino, Said Mohamed Anwar Elgendy, Michael Finbarr Scully
  • Patent number: 5858979
    Abstract: This invention provides peptides of the formula ##STR1## wherein X is H, CH.sub.3 or an N-protecting group;Y is(1) C.sub.3 -C.sub.9 alkyl optionally substituted by C.sub.1 -C.sub.4 alkoxy,(2) C.sub.5 -C.sub.10 aryl optionally substituted by C.sub.1 -C.sub.4 alkoxy,(3) C.sub.5 -C.sub.10 alkylaryl optionally substituted by C.sub.1 -C.sub.4 alkoxy,(4) (CH.sub.2).sub.n --Q or ##STR2## wherein Q is H, amino, amidino, imidizole, guanidino or isothioureido and n is 1-5;Z is COR.sub.1, ##STR3## wherein: R.sub.1 is H, OH, CH.sub.2 Cl, CH.sub.2 --CH.sub.2 --CO-pip, CF.sub.2 --CF.sub.2 --CO-pip, CH.sub.2 --CH(CH.sub.3)--CO-pip, CF.sub.2 --CF(CF.sub.3)--CO-pip, CH.sub.2 --CH.sub.2 --CO-Pro-NHEt, CF.sub.2 --CF.sub.2 --CO-Pro-NHEt or a chromophoric group,R.sub.2 and R.sub.3 may be the same or different and are selected from the group consisting of OH, OR.sub.6 and NR.sub.6 R.sub.7, wherein R.sub.6 and R.sub.7 may be the same or different and are selected from the group consisting of C.sub.1-10 alkyl, phenyl or C.sub.6 -C.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: January 12, 1999
    Assignee: Trigen Limited
    Inventors: Vijay Vir Kakkar, John Joseph Deadman, Goran Karl Claeson, Leifeng Cheng, Naoyashi Chino, Said Mohamed Anwar Elgendy, Michael Finbarr Scully
  • Patent number: 5648338
    Abstract: Peptides which act as inhibitors or substrates of thrombin are derived from the formula: D-Phe-Pro-Arg or its analogues, wherein Phe is substituted by (a), wherein Ar.sub.1 or Ar.sub.2 are the same or different and are selected from the group consisting of phenyl, thienyl, pyridyl, naphthyl, thionaphtyl, indolyl and saturated groups corresponding to these, optionally substituted by up to three groups selected from C.sub.1 -C.sub.3 alkyl and C.sub.1 -C.sub.3 alkoxy, L.sub.1 and L.sub.2 are the same of different and are selected from the group consisting of CH.sub.2, C.sub.2 --C.sub.2, O-CH.sub.2, S-CH.sub.2, Ar-L taken together optionally means H, diphenyl-methyl, fluorenyl or saturated groups corresponding to these, but one of the Ar-L cannot be H when the other [CH.sub.2 ].sub.n -Q, (c) where Q=H, amino, amidino, imidazole, guanidino or isothioureido and n=1-5, preferably 3-5, or C.sub.3 -C.sub.9 alkyl and C.sub.5 -C.sub.
    Type: Grant
    Filed: October 4, 1994
    Date of Patent: July 15, 1997
    Assignee: Thrombosis Research Institute
    Inventors: Vijay Vir Kakkar, John Joseph Deadman, Goran Karl Claeson, Leifeng Cheng, Naoyashi Chino, Said Mohamed Anwar Elgendy, Michael Finbarr Scully